{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiei7icgsxvg5cyal7day52w3xoer43dx4l6h55wk55lp5ryg2cv5u",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mlsx33cyqrp2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiab7sjbnt6urpzgmy77nohda6mvhv7rukfxjpvayvemjqkx7r7ogi"
    },
    "mimeType": "image/jpeg",
    "size": 863716
  },
  "path": "/news/2026-05-cancer-fatigue-ease-weeks-common.html",
  "publishedAt": "2026-05-14T09:00:02.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new meta-analysis in Journal of the National Comprehensive Cancer Network provides updated evidence that methylphenidate-type psychostimulants—a class of medication that increases dopamine and norepinephrine availability in the brain—can provide meaningful relief for cancer-related fatigue.",
  "title": "Cancer fatigue may ease within weeks as common stimulant shows benefit"
}